US20080311606 Methods for monitoring patients for efficacy of an antiplatelet therapy regimen

Settings

Stemming

Single Family Member

Include NPL

Office

United States of America

Application Number 11658367

Application Date 26.07.2005

Publication Number 20080311606

Publication Date 18.12.2008

Grant Number 7723064

Grant Date 25.05.2010

Publication Kind B2

IPC

CPC

Applicants Siemens Healthcare Diagnostics Inc.

Inventors Chapman-Montgomery E. Sabrinah
Okrongly David
Grant Andrew McGregor
Ahnadi Charaf E.
Wu Alan
Gervais Andre

Agents Pollack Norm R.

Title

(EN) Methods for monitoring patients for efficacy of an antiplatelet therapy regimen

Abstract

(EN)

Methods are disclosed for monitoring patients utilizing Mean Platelet Component values during therapeutic intervention.

C	CHEMISTRY; METALLURGY
12	BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q	MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1	Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
56	involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

C	CHEMISTRY; METALLURGY
12	BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q	MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1	Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
56	involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

G	PHYSICS
01	MEASURING; TESTING
N	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33	Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48	Biological material, e.g. blood, urine
50	Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53	Immunoassay; Biospecific binding assay; Materials therefor
569	for microorganisms, e.g. protozoa, bacteria, viruses
56966	Animal cells
56972	White blood cells

G	PHYSICS
01	MEASURING; TESTING
N	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333	Assays involving biological materials from specific organisms or of a specific nature
435	from animals; from humans
46	from vertebrates
47	Assays involving proteins of known structure or function as defined in the subgroups
4701	Details
4737	C-reactive protein

G	PHYSICS
01	MEASURING; TESTING
N	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800	Detection or diagnosis of diseases
32	Cardiovascular disorders
324	Coronary artery diseases, e.g. angina pectoris, myocardial infarction